Industry Background and Basic Composition of Pricing Standards for Polypeptide Products
The pricing standards for polypeptide products are not merely a single figure, but a dynamic system determined by multiple variables. Across different application scenarios including peptide research reagents, cosmetic raw materials and pharmaceutical intermediates, discrepancies in peptide product prices can reach dozens or even hundreds of times. Take a short peptide with only 5 amino acids as an example. Its crude product may cost just a few RMB per milligram. In contrast, a 30-mer peptide with fluorescent labeling, phosphorylation modification and purity above 98% can have quotations soaring to hundreds of RMB per milligram. This wide price range directly reflects the complexity of the pricing standards for polypeptide products.
In terms of basic composition, the pricing standards for polypeptide products generally consist of four major modules: synthesis cost, purification cost, quality inspection cost, packaging and transportation cost. Synthesis cost is directly linked to the number of amino acids and sequence difficulty; purification cost depends on the target purity level; quality inspection cost covers routine tests such as HPLC and MS; packaging and transportation involve special requirements like lyophilization and cold chain. Understanding this composition is the first step to judge whether a quotation is reasonable. Many buyers, when first encountering the pricing standards for polypeptide products, tend to focus only on the total price while ignoring the breakdown logic of each module, which later leads to budget deviations.
In addition, market supply and demand also have a periodical impact on the pricing standards for polypeptide products. For example, during the boom in GLP-1 peptide drug R&D, the synthesis demand for related sequences surged, some suppliers' lead times lengthened, and rush fees rose accordingly. Therefore, mastering the composition logic of pricing standards not only helps control procurement costs, but also helps secure more favorable terms in negotiation.
Core Factors Affecting Peptide Product Pricing Standards
The number of amino acids is the most intuitive factor affecting the pricing standards for polypeptide products. In general, short peptides with a sequence length of fewer than 10 amino acids feature low synthesis difficulty and relatively affordable prices. When the sequence extends to 20–30 amino acids, coupling efficiency drops, by-products increase, purification difficulty rises significantly, and the price curve becomes steep accordingly. Taking the public quotation from a supplier as an example, the price of a 10-mer peptide with 95% purity is approximately 15 RMB per milligram, while a 30-mer peptide of the same purity may cost 60 to 80 RMB per milligram. This non-linear growth stems from the fact that each coupling reaction requires excess activated amino acids and coupling reagents, and raw material costs accumulate exponentially with sequence length.
Sequence complexity is equally critical. If the sequence contains multiple hydrophobic amino acids, consecutive arginine or histidine residues, or fragments prone to aggregation, the synthesis difficulty will increase substantially. Such sequences often require special processes such as pseudoproline dipeptides and microwave-assisted synthesis, which directly push up peptide product pricing standards. In addition, if cysteine is present in the sequence, extra oxidative folding steps for disulfide bond formation must be considered, and this cost is usually listed as a separate item.
Purity grade is another decisive variable. Research-grade crude peptides, desalted peptides, 95% purity, 98% purity and even 99% purity — each upgrade means more complex preparative HPLC purification workflows and lower recovery rates. Boosting purity from 95% to 98% appears to be only a three-percentage-point increase, yet purification costs may rise by 30% to 50%. Therefore, purity is often the primary metric buyers need to weigh when reviewing the pricing standards for polypeptide products.
How Purity Grade Determines Peptide Product Pricing Standards
Purity is the core metric for evaluating the quality of polypeptide products and the most flexible component in peptide product pricing standards. Typically, suppliers offer several standard purity grades: crude peptide (around 70%), desalted peptide (around 80%), >95% and >98%. Crude peptides have the lowest price and are suitable for preliminary screening or immunological experiments with low purity requirements. In contrast, cell assays, receptor binding assays and animal studies usually require purity above 95% to prevent impurities from interfering with experimental results.
Take a 20-mer peptide as an example. Quotations from a domestic supplier show: crude peptide at approximately 5 RMB/mg, desalted peptide at about 8 RMB/mg, 95% purity at roughly 18 RMB/mg, and 98% purity at approximately 28 RMB/mg. The price increases by more than 50% from 95% to 98% purity. This is because preparative HPLC demands finer gradient elution conditions with narrower collection windows, and product recovery may drop sharply from 70% to below 40%. For large-scale projects, such cost differences will be greatly amplified.
It is worth noting that the purity labeling method itself can also affect peptide product pricing standards. Some suppliers state purity by HPLC peak area percentage, while others use mass percentage. The former may overestimate the actual purity, whereas the latter is closer to the real content. When comparing quotations, buyers should clarify the purity detection method and evaluation criteria to avoid wrong decisions caused by inconsistent standards.
Synthesis Scale and Price Tiers: From Milligram to Kilogram Scale
The impact of synthesis scale on the pricing standards for polypeptide products follows an obvious scale effect. At the milligram scale, fixed costs such as resin, reagent initialization and QC testing dominate, resulting in high unit prices. When scaled up to the gram level, the unit price usually drops by 30% to 50%; at the kilogram scale or higher, the unit price may further decrease to one-tenth of the milligram quotation or even lower. This tiered pricing structure is the most economically significant part of polypeptide product pricing standards.
Specifically, a modified peptide is quoted at 100 RMB per milligram for milligram-scale orders, with a total cost of roughly 8000 RMB for 100 mg. If purchasing 1 gram in one batch, the unit price may fall to 40 RMB per milligram, with a total cost of about 40000 RMB. Although the total expenditure rises, the unit cost decreases substantially. For long-term projects, bulk purchase with aliquot storage and cryopreservation is often more economical than repeated small orders. Nevertheless, bulk procurement also requires consideration of peptide stability and storage conditions to prevent degradation during long-term storage.
In addition, the scale effect does not extend infinitely in a linear fashion. Once the scale exceeds a certain threshold, synthesis difficulty, purification load and quality control complexity also rise. Some special sequences cannot